CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19).
Dr Steven Narod
O. Harold Warwick Prize co-recipient in 2012
Dr Steven Narod is a world leader in the field of breast and ovarian cancer genetics. He has had a profound impact on cancer control in Canada, particularly in the areas of prevention, screening and inherited breast and ovarian cancer risk, specifically amongst carriers of BRCA1 and BRCA2 gene mutations.
In 1991, Dr Narod was the first to show that familial breast cancer genes were also linked to the development of ovarian cancer. Since then, his continued work in understanding BRCA genetic mutations has uncovered their associated risks and how the mutations are distributed within populations.
Dr Narod has identified founder mutations in a number of ethnically diverse populations; his database of over 13,000 women from 51 centres in 30 countries supports numerous international collaborations in countries around the world. He has explored a number of approaches shown to be effective at preventing breast and ovarian cancers in these high-risk populations. He is now evaluating the impacts of various surgical treatments and chemotherapy regimens on survival of women with hereditary breast cancer.
Dr Narod is a Tier I Canada Research Chair in Breast Cancer, a professor in the Dalla Lana School of Public Health and the department of medicine at the University of Toronto, and a senior scientist at Women’s College Research Institute, where he leads the Familial Breast Cancer Research Unit.
Dr Narod is a very productive researcher, with more than 550 peer-reviewed publications. In 2005, he was named the most-cited breast cancer researcher in the world. Dr Narod strives for excellence in research and is always willing to share ideas and support the careers of his trainees.
Taking action against all cancers
The latest Canadian Cancer Statistics report found that of all newly diagnosed cancers in 2017, half are expected to be lung, colorectal, breast and prostate cancers. Learn what you can do to reduce the burden of cancer.